Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
07 2020
Historique:
received: 22 01 2020
accepted: 25 04 2020
pubmed: 1 5 2020
medline: 31 12 2020
entrez: 1 5 2020
Statut: ppublish

Résumé

We conducted a two-sample Mendelian randomization study to investigate the causal associations of type 2 diabetes mellitus (T2DM) with risk of overall cancer and 22 site-specific cancers. Summary-level data for cancer were extracted from the Breast Cancer Association Consortium and UK Biobank. Genetic predisposition to T2DM was associated with higher odds of pancreatic, kidney, uterine, and cervical cancer and lower odds of esophageal cancer and melanoma but not associated with 16 other site-specific cancers or overall cancer. The odds ratios (ORs) were 1.13 (95% CI 1.04, 1.22), 1.08 (1.00, 1.17), 1.08 (1.01, 1.15), 1.07 (1.01, 1.15), 0.89 (0.81, 0.98), and 0.93 (0.89, 0.97) for pancreatic, kidney, uterine, cervical, and esophageal cancer and melanoma, respectively. The association between T2DM and pancreatic cancer was also observed in a meta-analysis of this and a previous Mendelian randomization study (OR 1.08; 95% CI 1.02, 1.14;

Identifiants

pubmed: 32349989
pii: db20-0084
doi: 10.2337/db20-0084
pmc: PMC7306131
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Banques de données

figshare
['10.2337/figshare.12200807']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1588-1596

Subventions

Organisme : Wellcome Trust
ID : 204623/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18281/A19169
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/7
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Informations de copyright

© 2020 by the American Diabetes Association.

Références

Ann Surg Oncol. 2014 Jul;21(7):2453-62
pubmed: 24609291
BMJ. 2001 Jan 27;322(7280):226-31
pubmed: 11159626
Cancer Causes Control. 2012 Feb;23(2):263-72
pubmed: 22094992
Diabetes Care. 2015 Feb;38(2):264-70
pubmed: 25488912
Diabetologia. 1999 Jan;42(1):107-12
pubmed: 10027588
Prostate Cancer Prostatic Dis. 2013 Jun;16(2):151-8, S1
pubmed: 23032360
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Ann Oncol. 2014 Oct;25(10):2065-72
pubmed: 25057164
Nat Genet. 2012 Sep;44(9):991-1005
pubmed: 22885924
Oncologist. 2010;15(6):548-55
pubmed: 20479278
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Int J Cancer. 2007 Aug 15;121(4):856-62
pubmed: 17397032
J Natl Cancer Inst. 2016 Jun 08;108(10):
pubmed: 27281756
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
Ann Epidemiol. 2016 Nov;26(11):764-772
pubmed: 27765402
J Clin Invest. 1986 Jan;77(1):322-5
pubmed: 3944257
BMC Cancer. 2019 May 31;19(1):527
pubmed: 31151429
Int J Cancer. 2016 Apr 1;138(7):1741-53
pubmed: 26547128
Diabetes Metab. 2012 Dec;38(6):475-84
pubmed: 23041441
Hormones (Athens). 2012 Jul-Sep;11(3):308-15
pubmed: 22908063
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Diabetologia. 2011 Sep;54(9):2263-71
pubmed: 21748485
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28954281
Metabolism. 2011 Oct;60(10):1372-8
pubmed: 21550085
Science. 2007 May 11;316(5826):889-94
pubmed: 17434869
Eur J Epidemiol. 2017 May;32(5):377-389
pubmed: 28527048
Br J Cancer. 2015 Dec 1;113(11):1607-14
pubmed: 26575601
Nat Commun. 2018 Feb 8;9(1):556
pubmed: 29422604
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
Diabetes Care. 2011 Jun;34(6):1365-8
pubmed: 21505205
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):921-9
pubmed: 18398032
PLoS One. 2017 Jun 8;12(6):e0177875
pubmed: 28594918
Eur J Cancer. 2011 Sep;47(13):1928-37
pubmed: 21458985
Diabet Med. 2007 Feb;24(2):200-7
pubmed: 17257284
Int J Epidemiol. 2013 Oct;42(5):1497-501
pubmed: 24159078
Diabetes Res Clin Pract. 2014 Oct;106(1):19-26
pubmed: 24837144
Nat Rev Urol. 2013 Jan;10(1):12-4
pubmed: 23208302
Clin Sci (Lond). 2009 Nov 23;118(5):315-32
pubmed: 19922415
Int J Cancer. 2015 Mar 15;136(6):1402-10
pubmed: 25066446
J Natl Cancer Inst. 2015 Jul 01;107(9):
pubmed: 26134033
Int J Cancer. 2011 Feb 1;128(3):635-43
pubmed: 20473855
Nat Genet. 2018 May;50(5):693-698
pubmed: 29686387
Diabetes Care. 2015 Jul;38(7):1356-64
pubmed: 25877811
Int J Cancer. 2020 Feb 1;146(3):712-719
pubmed: 30927373
Diabetes Care. 2001 May;24(5):843-9
pubmed: 11347741
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
Am J Clin Nutr. 2010 Aug;92(2):347-52
pubmed: 20519560
Diabetes. 2017 May;66(5):1103-1110
pubmed: 28507210
JAMA. 2005 Dec 14;294(22):2872-8
pubmed: 16352795
Oncogene. 2012 May 31;31(22):2703-14
pubmed: 21963847
Diabetes Care. 2018 Jul;41(7):1432-1437
pubmed: 29678810
Diabetologia. 2007 Jul;50(7):1365-74
pubmed: 17476474
Ann Oncol. 2016 Dec;27(12):2184-2195
pubmed: 27681864
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
World J Gastroenterol. 2015 May 21;21(19):6026-31
pubmed: 26019469
Ann Transl Med. 2014 Jun;2(6):57
pubmed: 25333032
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
PLoS Med. 2019 Aug 7;16(8):e1002893
pubmed: 31390370
PLoS Med. 2019 Jan 3;16(1):e1002724
pubmed: 30605491
BMC Gastroenterol. 2012 Dec 12;12:177
pubmed: 23234272
Neurology. 2017 Aug 1;89(5):454-460
pubmed: 28667182
Diabetologia. 2006 May;49(5):945-52
pubmed: 16557372
BMJ Open Diabetes Res Care. 2019 Dec 29;7(1):e000872
pubmed: 31908803
Diabetologia. 2011 May;54(5):1013-8
pubmed: 21274512
Medicine (Baltimore). 2017 Sep;96(35):e7944
pubmed: 28858123
J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87
pubmed: 16288121

Auteurs

Shuai Yuan (S)

Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Siddhartha Kar (S)

MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, U.K.

Paul Carter (P)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K.

Mathew Vithayathil (M)

MRC Cancer Unit, University of Cambridge, Cambridge, U.K.

Amy M Mason (AM)

British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K.
National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, U.K.

Stephen Burgess (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, U.K.
MRC Biostatistics Unit, University of Cambridge, Cambridge, U.K.

Susanna C Larsson (SC)

Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden susanna.larsson@ki.se.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH